Pharma Capital

Featured articles

VIEW ALL ARTICLES

Featured companies

We are a drug development company with a proprietary genetic medicine platform Our technol...
Regeneus Ltd (ASX:RGS) is a clinical-stage regenerative medicine company developing a portfoli...
ImmuPharma PLC is a pharmaceutical company listed since 2006 on AIM of the London Stock Exchan...
OUR VISION Unibio’s vision is to be the leading producer of methane based products, such a...
OptiBiotix was formed in March 2012 to develop compounds which modify the human microbiome - t...
SkinBioTherapeutics plc is developing innovative treatments for human skin using a technology,...

Executive video interviews

VIEW ALL VIDEOS

Big picture investment ideas in Biotech Capital

VIEW ALL

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.